The CLIP1–LTK fusion is an oncogenic driver in non‐small‐cell lung cancer

Oncogenic driver mutations in lung cancer, Translational Respiratory Medicine

Biomolecules, Free Full-Text

2022肺癌靶标热点追击，ERRα/LTK/EMSY初露锋芒-源井生物- 知乎

ROS1-dependent cancers — biology, diagnostics and therapeutics

Empire Genomics Interviews With Today's Leading Researchers & Clinicians

Genotype-phenotype mapping of a patient-derived lung cancer organoid biobank identifies NKX2-1-defined Wnt dependency in lung adenocarcinoma - ScienceDirect

The CLIP1-LTK fusion is an oncogenic driver in non-small-cell lung cancer. - Abstract - Europe PMC

Clinical and Translational Implications of RET Rearrangements in Non–Small Cell Lung Cancer - ScienceDirect

Identification of Ultrasound-Sensitive Prognostic Markers of LAML and Construction of Prognostic Risk Model Based on WGCNA

The CLIP1–LTK fusion is an oncogenic driver in non‐small‐cell lung cancer